Search results for "structures"

showing 10 items of 4815 documents

Biomarkers for glaucoma: from the lab to the clinic

2017

Glaucoma, a leading cause of irreversible blindness worldwide, is often not diagnosed until many years after disease onset. Early and objective diagnostic measures are yet missing. Besides the main risk factor, an elevated intraocular pressure (IOP), age, sex, and ethnicity are known to affect disease progression and severity. Furthermore, oxidative stress, elevated glutamate concentrations, and an autoimmune component are considered possible risk factors. We could identify several potential proteomic biomarkers in glaucoma and examine distinct changes in the glaucomatous human retina proteome. Using an experimental autoimmune glaucoma animal (EAG) model we could demonstrate an IOP-independ…

ProteomicsRetinal Ganglion CellsIntraocular pressuremedicine.medical_specialtygenetic structuresSwineGlaucomaAutoimmunitymedicine.disease_causeRetinal ganglionRetinaAutoimmunity03 medical and health sciences0302 clinical medicineOphthalmologyMedicineAnimalsHumansIntraocular PressureAutoantibodiesRetinabusiness.industryAutoantibodyGlaucomamedicine.diseaseeye diseasesCambridge Ophthalmological SymposiumOphthalmologyDisease Models Animalmedicine.anatomical_structureImmunoglobulin GImmunology030221 ophthalmology & optometryOptic nerveDisease ProgressionBiomarker (medicine)sense organsMicrogliabusiness030217 neurology & neurosurgeryBiomarkers
researchProduct

Serum and antibodies of glaucoma patients lead to changes in the proteome, especially cell regulatory proteins, in retinal cells.

2012

PURPOSE: Previous studies show significantly specifically changed autoantibody reactions against retinal antigens in the serum of glaucoma and ocular hypertension (OHT) patients in comparison to healthy people. As pathogenesis of glaucoma still is unknown the aim of this study was to analyze if the serum and antibodies of glaucoma patients interact with neuroretinal cells. METHODS: R28 cells were incubated with serum of patients suffering from primary open angle glaucoma (POAG), normal tension glaucoma (NTG) or OHT, POAG serum after antibody removal and serum from healthy people for 48 h under a normal or an elevated pressure of 15000 Pa (112 mmHg). RGC5 cells were additionally incubated wi…

ProteomicsRetinal Ganglion CellsSerumProteomegenetic structuresOcular hypertensionGlaucomalcsh:MedicineAutoimmunityPathogenesischemistry.chemical_compoundMolecular Cell Biologylcsh:ScienceCellular Stress ResponsesMultidisciplinarySpectrometric Identification of ProteinsbiologyNeurodegenerative DiseasesBlood proteinsSignaling CascadesNeurologyMedicineRetinal DisordersElectrophoresis Polyacrylamide GelAntibodyGlaucoma Open-AngleRetinal NeuronsSignal TransductionResearch ArticleSpectrometry Mass Electrospray IonizationImmunologyImmunoglobulinsPeptide MappingAntibodiesStress Signaling CascadeCell LineAntigenmedicinePressureAnimalsHumansBiologylcsh:RAutoantibodyRetinalGlaucomamedicine.diseaseeye diseasesRatsOphthalmologychemistrySpectrometry Mass Matrix-Assisted Laser Desorption-IonizationImmunologybiology.proteinOcular HypertensionClinical Immunologylcsh:Qsense organsChromatography LiquidPLoS ONE
researchProduct

CiliaCarta: An integrated and validated compendium of ciliary genes

2019

The cilium is an essential organelle at the surface of mammalian cells whose dysfunction causes a wide range of genetic diseases collectively called ciliopathies. The current rate at which new ciliopathy genes are identified suggests that many ciliary components remain undiscovered. We generated and rigorously analyzed genomic, proteomic, transcriptomic and evolutionary data and systematically integrated these using Bayesian statistics into a predictive score for ciliary function. This resulted in 285 candidate ciliary genes. We generated independent experimental evidence of ciliary associations for 24 out of 36 analyzed candidate proteins using multiple cell and animal model systems (mouse…

ProteomicsSensory ReceptorsNematodaSocial SciencesCiliopathiesBiochemistrySensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]Transcriptome0302 clinical medicineAnimal CellsPsychologyRETINAL PHOTORECEPTOR CELLSExomeNeurons0303 health sciences030302 biochemistry & molecular biologyEukaryotaGenomicsPRIMARY CILIUMthecilium3. Good healthNucleic acidsGenetic interferenceOsteichthyesMedicineEpigeneticsCellular Structures and OrganellesCellular Typesproteomic databasesSensory Receptor CellsScienceeducationCiliary genesLEBER CONGENITAL AMAUROSISGenomics03 medical and health sciencesGeneticsCiliaCaenorhabditis elegansIDENTIFICATIONMUTATIONSEmbryosciliaOrganismsBiology and Life SciencesBayes TheoremMolecular Sequence Annotationmedicine.diseaseInvertebratesFishciliary proteomeAnimal StudiesCaenorhabditisGene expressionembryos030217 neurology & neurosurgeryDevelopmental BiologyNeurosciencePhotoreceptorsCandidate geneEmbryologyOligonucleotidesMorpholinoDatabase and Informatics MethodsRNA interferenceBayesian classifierTRANSITION ZONEZebrafishAntisense OligonucleotidesZebrafishGeneticsMultidisciplinarySpectrometric Identification of ProteinsProteomic DatabasesNucleotidesCiliumQStable Isotope Labeling by Amino Acids in Cell CultureRphotoreceptorsMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]Animal ModelsPhenotypeINTRAFLAGELLAR TRANSPORTDIFFERENTIATIONPhenotypeExperimental Organism SystemsCaenorhabditis ElegansVertebratesSensory PerceptionResearch ArticleSignal TransductionEXPRESSIONStable isotope labeling by amino acids in cell cultureComputational biologyBiologyResearch and Analysis MethodsSOLUTE-CARRIER-PROTEINModel OrganismsmedicineAnimalsdata integration030304 developmental biologyAfferent NeuronsReproducibility of ResultsCell Biologyzebrafishbiology.organism_classificationCiliopathyRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]Biological DatabasesCellular NeuroscienceRNAOSCP1CiliaCartaPLoS ONE
researchProduct

RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization

2021

Age-related macular degeneration (AMD) is an eye disease that is characterized by damage to the central part of the retina, the macula, and that affects millions of people worldwide. At an advanced stage, a blind spot grows in the center of vision, severely handicapping patients with this degenerative condition. Despite therapeutic advances thanks to the use of anti-VEGF, many resistance mechanisms have been found to accentuate the visual deficit. In the present study, we explored whether supplementation with Resvega®, a nutraceutical formulation composed of omega-3 fatty acids and resveratrol, a well-known polyphenol in grapes, was able to counteract laser-induced choroidal neovascularizat…

Proteomicsgenetic structuresAngiogenesisAMDresveratrolPharmacologyResveratrolMacular DegenerationMiceangiogenesischemistry.chemical_compound0302 clinical medicineMedicineBiology (General)proteomicSpectroscopy0303 health sciencesomega-3 fatty acidsGeneral Medicine3. Good healthComputer Science ApplicationsChemistrymedicine.anatomical_structureChoroidal neovascularization[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFemalemedicine.symptomQH301-705.5ArticleCatalysisInorganic Chemistry03 medical and health sciencesNutraceuticalIn vivoFatty Acids Omega-3[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologyAnimals[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyIn patient[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansPhysical and Theoretical ChemistryQD1-999Molecular Biology030304 developmental biologyRetinabusiness.industryocular diseasesOrganic ChemistryMacular degenerationmedicine.diseaseChoroidal Neovascularizationeye diseasesDisease Models Animal[SDV.AEN] Life Sciences [q-bio]/Food and NutritionchemistryDietary Supplements030221 ophthalmology & optometrysense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionInternational Journal of Molecular Sciences
researchProduct

Pharmacological interventions for schizotypal personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over a year due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistPharmacological interventionsgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSmedicineAlternative medicinemedicine.diseasebusinessSchizotypal personality disorderArticle
researchProduct

Psychological interventions for obsessive-compulsive personality disorder

2010

Reason for withdrawal from publication Authors have made no progress with this protocol in over three years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSAlternative medicinePsychological interventionMEDLINEmedicine.diseaseArticleObsessive–compulsive personality disordermedicinebusiness
researchProduct

Pharmacological interventions for paranoid personality disorder

2014

Reason for withdrawal from publication Authors have made no progress with this protocol in over three years due to difficulties with identifying potentially suitable studies. The protocol has been withdrawn. To view the published versions of this article, please click the 'Other versions' tab.

Protocol (science)medicine.medical_specialtyPsychotherapistgenetic structuresbusiness.industryComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSMEDLINEAlternative medicinemedicine.diseaseArticlePharmacological interventionsParanoid personality disordermedicinebusiness
researchProduct

A Constructive Arboricity Approximation Scheme

2020

The arboricity \(\varGamma \) of a graph is the minimum number of forests its edge set can be partitioned into. Previous approximation schemes were nonconstructive, i.e., they approximate the arboricity as a value without computing a corresponding forest partition. This is because they operate on pseudoforest partitions or the dual problem of finding dense subgraphs.

PseudoforestArboricityApproximation algorithm0102 computer and information sciences02 engineering and technology01 natural sciencesConstructiveCombinatoricsSet (abstract data type)Computer Science::Discrete Mathematics010201 computation theory & mathematics0202 electrical engineering electronic engineering information engineeringGraph (abstract data type)Partition (number theory)020201 artificial intelligence & image processingMatroid partitioningComputer Science::Data Structures and AlgorithmsGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Computer Science::Distributed Parallel and Cluster ComputingMathematicsofComputing_DISCRETEMATHEMATICSMathematics
researchProduct

Spanish Validation of the Multidimensional Existential Meaning Scale: Which Dimension of Meaning in Life Is More Associated With Psychopathology in P…

2022

BackgroundTo assess three dimensions of Meaning in Life (comprehension, purpose, and mattering) the Multidimensional Existential Meaning Scale (MEMS) was developed, however, the MEMS's factorial structure has not yet been confirmed in a Spanish-speaking sample. A question that remains unanswered is which of the three dimensions of MiL are associated with psychopathology in clinical samples.Aims(1) to analyze the psychometric properties of the MEMS in a Spanish non-clinical population, and (2) to identify which of the three dimensions of MiL shows the strongest relationship with depression, anxiety and positive affect in a clinical population.MethodThe non-clinical sample, consisted of N = 1…

PsychiatryPsychiatry and Mental healthmeaning in lifeembryonic structuresRC435-571matteringpurposepositive affectcoherenceFrontiers in psychiatry
researchProduct

A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis

2021

Introduction: There is evidence that early intervention contributes to improving the prognosis and course of first-episode psychosis (FEP). However, further randomised treatment clinical trials are needed. Objectives: The aim of this study was to compare the efficacy of a combined clinical treatment involving Cognitive Behavioural Therapy (CBT) as an adjunctive to treatment-as-usual (TAU) (CBT+TAU) versus TAU alone for FEP. Patients and methods: In this multicentre, single-blind, randomised controlled trial, 177 participants were randomly allocated to either CBT+TAU or TAU. The primary outcome was post-treatment patient functioning. Results: The CBT+TAU group showed a greater improvement in…

Psychosismedicine.medical_specialtyanimal structuresPronòstic mèdicHealth Toxicology and MutagenesisPsicosiDiseasebehavioral disciplines and activitiesArticlelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawIntervention (counseling)Internal medicinemental disordersmedicineScopusHumansSingle-Blind Methodfirst-episode psychosisClinical treatmenttreatmentCognitive Behavioral Therapybusiness.industryStandard treatmentRPublic Health Environmental and Occupational HealthPsychosesCognitionmedicine.diseasePrognosisCombined Modality Therapy030227 psychiatryClinical trialTreatment Adherence and Complianceearly interventionTreatment OutcomePsychotic DisordersJCRSchizophreniaoutcomeMedicineEsquizofrèniabusinessrandomised controlled trial030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct